Literature DB >> 12612748

[Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].

Maria Aurélia F Porto1, André Muniz, Jamary Oliveira Júnior, Edgar Marcelino Carvalho.   

Abstract

Strongyloidiasis is one of most important forms of helminthiasis in tropical countries and epidemiologic studies have shown the association of this parasitic disease with HTLV. It has been observed in regions where both these agents are endemic and coinfection may result in an increase in the disseminated forms of strongyloidiasis as well as recurrent strongyloidiasis. While HTLV-1 is related to a high production of IFN-gamma; and deviation of the immune response towards a Th1 response, the protection against helminths is associated with Th2 like immune response. Individuals infected with HTLV and S. stercoralis have a reduction in the production of IL-4, IL-5, IL-13 and parasitic IgE response, all of which are factors participating in the defense mechanism against S. stercoralis. These abnormalities are the basis for the occurrence of an increase in the severe forms of strongyloidiasis among patients infected with HTLV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612748     DOI: 10.1590/s0037-86822002000600016

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  9 in total

1.  Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected mice.

Authors:  Michelle Carvalho de Rezende; Emília Souza Araújo; João Marcelo Peixoto Moreira; Vanessa Fernandes Rodrigues; Jailza Lima Rodrigues; Cíntia A de Jesus Pereira; Deborah Negrão-Corrêa
Journal:  Parasitol Res       Date:  2015-09-09       Impact factor: 2.289

2.  Helminthic infection and the risk of neurologic disease progression in HTLV-1.

Authors:  Michael A Sundberg; Davi Costa; Gloria Orge; Néviton M Castro; André Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Clin Virol       Date:  2012-01-10       Impact factor: 3.168

3.  Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis.

Authors:  M de Lourdes Bastos; B Osterbauer; D L Mesquita; C A Carrera; M J Albuquerque; L Silva; D N Pereira; L Riley; E M Carvalho
Journal:  Int J Tuberc Lung Dis       Date:  2009-12       Impact factor: 2.373

4.  Strongyloides stercoralis hyperinfection associated with impaired intestinal motility disorder.

Authors:  Cláudia Frangioia Figueira; Márcio Teodoro da Costa Gaspar; Lynda Dorene Cos; Edson Yassushi Ussami; José Pinhata Otoch; Aloisio Felipe-Silva
Journal:  Autops Case Rep       Date:  2015-06-30

5.  Human T Lymphotropic virus-1 associated gastrointestinal histoplasmosis in Peru.

Authors:  Carlos Canelo-Aybar; Jose Cuadra-Urteaga; Fernando Atencia; Franco Romani
Journal:  J Infect Dev Ctries       Date:  2011-07-04       Impact factor: 0.968

6.  Strongyloides Hyperinfection Syndrome causing fatal meningitis and septicemia by Citrobacter koseri.

Authors:  Felix Reyes; Navneet Singh; Nigar Anjuman-Khurram; Jihae Lee; Lillian Chow
Journal:  IDCases       Date:  2017-09-20

Review 7.  Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug Research.

Authors:  Tiago Mendes; Karen Minori; Marlene Ueta; Danilo Ciccone Miguel; Silmara Marques Allegretti
Journal:  J Parasitol Res       Date:  2017-01-22

Review 8.  Strongyloides stercoralis Infection in Alcoholic Patients.

Authors:  Marcia C A Teixeira; Flavia T F Pacheco; Joelma N Souza; Mônica L S Silva; Elizabete J Inês; Neci M Soares
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

9.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.